Showing results (21-30 of 305) with videos related to
Sort By:
Pageof 31
European Journal of Clinical Pharmacology|September 1, 1979
Enhancement of hepatic drug metabolism by glutethimide in patients with liver diseaseG C Farrell, W G Cooksley, L W PowellAustralian and New Zealand Journal of Medicine|February 1, 1976
Haemolysis in liver disease: relationship to erythrocyte membrane function, serum bilirubin concentration and plasma electrolyte disturbancesL W Powell, J W Halliday, W G CooksleyCancer Detection and Prevention|January 1, 1994
p53 gene in hepatocellular carcinomas from AustraliaD A Vesey, N K Hayward, W G CooksleyClinical and Experimental Immunology|March 1, 1980
Cell-mediated immunity to liver antigen in toxic liver injury. I. Occurrence and specificityC I Smith, W G Cooksley, L W PowellClinical Science (London, England : 1979)|March 1, 1985
A comparison of cobalamin binding by liver and kidney in rat and manJ S Scott, E P Bowman, W G CooksleyClinical Science (London, England : 1979)|May 1, 1985
The retention of cobalamin by the liver in the cobalamin-deficient ratJ A Owens, J S Scott, W G CooksleyThe Journal of Infectious Diseases|April 1, 1994
Infection of human bone marrow stromal cells by hepatitis B virus: implications for viral persistence and the suppression of hematopoiesisT Chai, S Prior, W G Cooksley, et al.Journal of Viral Hepatitis|October 6, 1997
Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study GroupG Farrell, W G Cooksley, F J Dudley, et al.British Medical Journal|July 17, 1976
Enhanced drug metabolism in cigarette smokersP Hart, G C Farrell, W G Cooksley, et al.Gastroenterology|October 1, 1978
Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolismG C Farrell, W G Cooksley, P Hart, et al.Pageof 31